美国妇科癌症诊断分期趋势(2001-2019):社会决定因素、地理差异与专科可及性的影响
基于美国癌症统计数据库2001至2019年1,398,959例子宫内膜癌、卵巢癌、宫颈癌或子宫肉瘤患者的横断面研究,采用多水平logistic回归分析发现,非西班牙裔黑人女性、高社会脆弱性县居民及无妇科肿瘤专科医生可及地区的患者晚期诊断风险显著升高。研究期间晚期宫颈癌诊断下降,而晚期子宫内膜癌和子宫肉瘤诊断增加。
要点
- 非西班牙裔黑人女性所有癌种晚期诊断调整OR为3.22-6.80,西班牙裔为2.89-3.50,亚裔/太平洋岛民为2.71-3.22。
- 高社会脆弱性县居民晚期诊断调整OR为2.64-3.11,最低地理可及性五分位(100英里内无妇科肿瘤医生)调整OR为2.23-2.86。
- 子宫内膜癌和宫颈癌中种族/民族与社会脆弱性存在交互作用,高脆弱性县中种族差异进一步扩大。
核心结论
- 妇科癌症诊断分期差异由种族/民族、社会脆弱性和专科医疗地理可及性共同驱动。
- 需在服务不足地区扩增妇科肿瘤人力资源并实施文化适配的早期检测项目。
研究设计与样本
- 基于美国癌症统计限制使用数据库的人群横断面研究,纳入2001至2019年1,398,959例妇科癌症患者。
- 暴露包括个体水平种族/民族、年龄和诊断日历年,县水平社会脆弱性指数四分位和两步浮动集水区法计算的妇科肿瘤医生地理可及性五分位。
- 主要结局为按国际妇产科联盟标准判定的晚期与早期诊断,采用多水平logistic回归估计调整OR和95%CI。
主要发现
- 非西班牙裔黑人女性所有癌种晚期诊断调整OR范围为3.22-6.80(均P<.05),西班牙裔为2.89-3.50,亚裔/太平洋岛民为2.71-3.22。
- 高社会脆弱性县居民晚期诊断调整OR范围为2.64-3.11(均P<.05)。
- 最低地理可及性五分位(100英里内无妇科肿瘤医生)晚期诊断调整OR范围为2.23-2.86(均P<.05)。
- 子宫内膜癌和宫颈癌中识别出种族/民族与社会脆弱性交互作用,高脆弱性县中种族差异进一步升高。
- 研究期间晚期宫颈癌诊断下降,晚期子宫内膜癌和子宫肉瘤诊断增加。
临床怎么用
- 临床接诊时应关注患者种族/民族、居住县社会脆弱性及妇科肿瘤专科可及性等分层因素对晚期诊断风险的影响。
- 在低可及性地区可考虑远程会诊或外展服务以弥补妇科肿瘤专科医生短缺。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Disparities in gynecologic cancer stage at diagnosis, driven by race/ethnicity, socioeconomic disadvantage, and geographic barriers to specialty care, contribute to worse outcomes in marginalized populations. The combined influence of social vulnerability and access to gynecologic oncologists on stage at diagnosis remains incompletely characterized at the national level. OBJECTIVE: To examine trends in gynecologic cancer stage at diagnosis from 2001 to 2019 and evaluate the effects of race/ethnicity, social vulnerability, and geographic access to gynecologic oncologists on late-stage diagnosis. STUDY DESIGN: Population-based cross-sectional study using the United States Cancer Statistics restricted-use database. A total of 1,398,959 individuals diagnosed with endometrial cancer, ovarian cancer, cervical cancer, or uterine sarcoma from 2001 to 2019 were included. Exposures included race/ethnicity, age, and calendar period of diagnosis at the individual level, and Social Vulnerability Index quartile (low, low-medium, medium-high, high) and geographic access to gynecologic oncologists categorized into quintiles via the 2-step floating catchment area method at the county level. The primary outcome was late-versus early-stage diagnosis per International Federation of Gynecology and Obstetrics criteria. Multilevel logistic regression estimated adjusted odds ratios and 95% confidence intervals for each cancer type. RESULTS: Late-stage diagnosis was significantly more likely among non-Hispanic Black women across all cancer types (adjusted odds ratio range: 3.22-6.80; all P<.05) compared to non-Hispanic White women, as well as among Hispanic women (adjusted odds ratio range: 2.89-3.50) and Asian/Pacific Islander women (adjusted odds ratio range: 2.71-3.22). Residence in high social vulnerability counties was associated with increased odds of late-stage diagnosis (adjusted odds ratio range: 2.64-3.11; all P<.05) relative to low vulnerability counties. Women in the lowest geographic access quintile, representing counties with no gynecologic oncologist within 100 miles, had higher odds of late-stage diagnosis than those in the highest quintile (adjusted odds ratio range: 2.23-2.86; all P<.05). Race/ethnicity and social vulnerability interactions were identified for endometrial and cervical cancers, indicating that race/ethnicity associations with late-stage diagnosis were further elevated in higher versus low vulnerability counties. Late-stage cervical cancer diagnoses declined over the study period, while late-stage endometrial cancer and uterine sarcoma diagnoses increased. CONCLUSION: Disparities in gynecologic cancer stage at diagnosis are driven by race/ethnicity, social vulnerability, and poor geographic access to specialty care. Targeted strategies, including gynecologic oncology workforce expansion in underserved areas and culturally tailored early detection programs, are needed to reduce late-stage diagnosis and improve outcomes in marginalized communities.
引用
- Desjardins MR, Desravines N, Patel V, et al. Trends in US gynecologic cancers (2001-2019): influence of social determinants, geographic disparities, and specialist access on stage at diagnosis. Am J Obstet Gynecol. 2026. PMID: 42624396. doi:10.1016/j.ajog.2026.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。